A study to evaluate the effect of dapagliflozin with and without saxagliptin on albuminuria, and to investigate the effect of dapagliflozin and saxagliptin on hba1c in patients with type 2 diabetes and CKD3

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this clinical research study is to determine whether dapagliflozin alone or in combination with saxagliptin can decrease albuminuria and improve glycemic control in patients with Type 2 diabetes, albuminuria and renal impairment (CKD). The study is planned to randomize a total of 450 patients (150 patients per treatment arm)
Epistemonikos ID: 7068013dea9026dd0f2ec2c36a6506c206ff7b48
First added on: May 12, 2024